Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1967 1
1968 1
1969 1
1977 1
1981 1
1987 1
1995 1
1998 2
1999 1
2000 1
2001 5
2002 4
2003 2
2004 5
2005 1
2006 6
2007 7
2008 8
2009 9
2010 6
2011 20
2012 11
2013 8
2014 14
2015 18
2016 22
2017 13
2018 16
2019 17
2020 29
2021 21
2022 20
2023 30
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Results by year

Filters applied: . Clear all
Page 1
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S; US Flu Vaccine Effectiveness Network Investigators. Bi Q, et al. Among authors: flannery b. J Infect Dis. 2024 Apr 30:jiae220. doi: 10.1093/infdis/jiae220. Online ahead of print. J Infect Dis. 2024. PMID: 38687898
Paired metagenomic and chemical evaluation of aflatoxin-contaminated dog kibble.
Ottesen A, Kocurek B, Reed E, Commichaux S, Mammel M, Ramachandran P, McDermott P, Flannery BM, Strain E. Ottesen A, et al. Among authors: flannery bm. Front Vet Sci. 2024 Apr 11;11:1374839. doi: 10.3389/fvets.2024.1374839. eCollection 2024. Front Vet Sci. 2024. PMID: 38665771 Free PMC article.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang DH, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Frutos AM, et al. Among authors: flannery b. MMWR Morb Mortal Wkly Rep. 2024 Feb 29;73(8):168-174. doi: 10.15585/mmwr.mm7308a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38421935 Free PMC article.
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Chung JR, Rogier E, Coughlin MM, Flannery B. Sumner KM, et al. Among authors: flannery b. J Infect Dis. 2024 Feb 23:jiae090. doi: 10.1093/infdis/jiae090. Online ahead of print. J Infect Dis. 2024. PMID: 38390968
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines.
Liu F, Gross FL, Joshi S, Gaglani M, Naleway AL, Murthy K, Groom HC, Wesley MG, Edwards LJ, Grant L, Kim SS, Sambhara S, Gangappa S, Tumpey T, Thompson MG, Fry AM, Flannery B, Dawood FS, Levine MZ. Liu F, et al. Among authors: flannery b. Nat Commun. 2024 Jan 4;15(1):254. doi: 10.1038/s41467-023-44551-x. Nat Commun. 2024. PMID: 38177116 Free PMC article. Clinical Trial.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
Tenforde MW, Weber ZA, Yang DH, DeSilva MB, Dascomb K, Irving SA, Naleway AL, Gaglani M, Fireman B, Lewis N, Zerbo O, Goddard K, Timbol J, Hansen JR, Grisel N, Arndorfer J, McEvoy CE, Essien IJ, Rao S, Grannis SJ, Kharbanda AB, Natarajan K, Ong TC, Embi PJ, Ball SW, Dunne MM, Kirshner L, Wiegand RE, Dickerson M, Patel P, Ray C, Flannery B, Garg S, Adams K, Klein NP. Tenforde MW, et al. Among authors: flannery b. J Infect Dis. 2023 Dec 2:jiad542. doi: 10.1093/infdis/jiad542. Online ahead of print. J Infect Dis. 2023. PMID: 38041853
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022.
Sandford R, Yadav R, Noble EK, Sumner K, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Carlson C, Coughlin M, Flannery B, Pearce B, Rogier E. Sandford R, et al. Among authors: flannery b. medRxiv [Preprint]. 2023 Nov 18:2023.11.17.23298700. doi: 10.1101/2023.11.17.23298700. medRxiv. 2023. PMID: 38014151 Free PMC article. Preprint.
291 results